LLY

1,177.42

+4.19%↑

JNJ

233.3

+0.28%↑

ABBV

225.86

-0.65%↓

UNH

402.18

+0.47%↑

MRK

121.76

+0.69%↑

LLY

1,177.42

+4.19%↑

JNJ

233.3

+0.28%↑

ABBV

225.86

-0.65%↓

UNH

402.18

+0.47%↑

MRK

121.76

+0.69%↑

LLY

1,177.42

+4.19%↑

JNJ

233.3

+0.28%↑

ABBV

225.86

-0.65%↓

UNH

402.18

+0.47%↑

MRK

121.76

+0.69%↑

LLY

1,177.42

+4.19%↑

JNJ

233.3

+0.28%↑

ABBV

225.86

-0.65%↓

UNH

402.18

+0.47%↑

MRK

121.76

+0.69%↑

LLY

1,177.42

+4.19%↑

JNJ

233.3

+0.28%↑

ABBV

225.86

-0.65%↓

UNH

402.18

+0.47%↑

MRK

121.76

+0.69%↑

Home・Stock List・Quanterix Corp

Quanterix Corp

Open

SectorHealthcare

3.28

Buy Sell

Overview

Share price change

24h

Current

Min

3.27

Max

3.34

Key metrics
By Trading Economics
Income	5.6M -18M
Sales	-7.4M 36M
EPS	0.16
Profit margin	-48.17
Employees	450
EBITDA	1.5M -15M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+21.21% upside

Dividends
By Dow Jones
Next Earnings	6 Aug 2026

Market Stats
By TradingEconomics
Market Cap	6.3M 165M
Previous open	3.28
Previous close	3.28

News Sentiment

By Acuity

50%

139 / 344 Healthcare

Quanterix Corp Chart

Past performance is not a reliable indicator of future results.

Related News

5 Jun 2026, 19:20 UTC

Major Market Movers

Meta Platforms Slips on Report of Plans for Multibillion-Dollar Offering to Fund AI Buildout

7 Jun 2026, 23:46 UTC

Market Talk

Nikkei Likely to Fall After U.S. Tech Selloff -- Market Talk

7 Jun 2026, 23:36 UTC

Market Talk

Oil Prices Rise Amid Escalating Supply Disruption Concerns -- Market Talk

7 Jun 2026, 18:00 UTC

Earnings

Inflation Readings, Oracle Earnings, the SpaceX IPO, and More to Watch This Week -- Barrons.com

6 Jun 2026, 12:40 UTC

Acquisitions, Mergers, Takeovers

Correction to Texas Billionaires Article America's Resort -- WSJ

6 Jun 2026, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

6 Jun 2026, 08:20 UTC

Market Talk

Financial Services Roundup: Market Talk

6 Jun 2026, 04:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 Jun 2026, 00:14 UTC

Acquisitions, Mergers, Takeovers

4 Arm Execs Sold $26 Million in Stock, but They Missed a High -- Barrons.com

5 Jun 2026, 21:27 UTC

Earnings

Carnage in Chip Stocks Hits Extra Hard in Top-Heavy Market -- WSJ

5 Jun 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

5 Jun 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

5 Jun 2026, 20:20 UTC

Acquisitions, Mergers, Takeovers

Altice France Group Had Granted Initial Exclusivity Period to Consortium Until May 15, Which Was Then Extended to June 5

5 Jun 2026, 20:19 UTC

Acquisitions, Mergers, Takeovers

Altice France Group, Bouygues Telecom, Free-iliad Group, Orange Exclusivity Period Extended by 48 Hours

5 Jun 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

5 Jun 2026, 19:26 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5 Jun 2026, 19:26 UTC

Market Talk

Hog Futures Tumble to Close Week -- Market Talk

5 Jun 2026, 19:10 UTC

Market Talk

Canada's GDP Targets From AI-Related Spending Require Second Look -- Market Talk

5 Jun 2026, 19:03 UTC

Market Talk

Oil Falls As Market Holds Out Hope for End to Conflict -- Market Talk

5 Jun 2026, 18:59 UTC

Market Talk

U.S. Natural-Gas Futures Pull Back After Gains -- Market Talk

5 Jun 2026, 18:47 UTC

Market Talk

Canada's Labor Market 'Retains Some Weakness' Despite Stellar May Report -- Market Talk

5 Jun 2026, 18:34 UTC

Market Talk

Hyperliquid ETFs Have Inflows Despite Crypto Weakness -- Market Talk

5 Jun 2026, 18:33 UTC

Acquisitions, Mergers, Takeovers

The U.S. Government Could Take a Stake in OpenAI. What That Means for Tech Stocks. -- Barrons.com

5 Jun 2026, 17:50 UTC

Earnings

Lululemon Slumps on Earnings. Bargain Hunters Beware. -- Barrons.com

5 Jun 2026, 17:27 UTC

Market Talk

U.S. Oil Rig Count Rises for 6th Straight Week -- Market Talk

5 Jun 2026, 16:48 UTC

Acquisitions, Mergers, Takeovers

Ryan Cohen Is Ready to Talk About eBay. For Real. -- Barrons.com

5 Jun 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

5 Jun 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

5 Jun 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

5 Jun 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

Peer Comparison

Price change

Quanterix Corp Forecast

Price Target

By TipRanks

21.21% upside

12 Months Forecast

Average 4 USD 21.21%

High 4 USD

Low 4 USD

Based on 2 Wall Street analysts offering 12 month price targets forQuanterix Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

2 ratings

Buy

Hold

Sell

Based on 2 analysts giving stock ratings to Quanterix Corp - Dist in the past 3 months.

Sentiment

By Acuity

139 / 344 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.